Meet the Measure

HPV Vaccine

Human papillomavirus (HPV) is the most common sexually transmitted infection in the United States. Some health effects caused by HPV can be prevented by the HPV vaccines.

HPV can cause cervical and other cancers.  Cancer often takes years, even decades to develop after a person gets HPV.  According to the CDC HPV infections and cervical precancers have dropped significantly since the vaccine has been in use in the United States:

  • Among teen girls, infections with HPV types that cause most HPV cancers and genital warts have dropped 86 percent.
  • Among young adult women, infections with HPV types that cause most HPV cancers and genital warts have dropped 71 percent.
  • Among vaccinated women, the percentage of cervical precancers caused by the HPV types most often linked to cervical cancer has dropped by 40 percent.

*US Centers for Disease Control and Prevention Website -Vaccinating Boys and Girls

Measure Description: BCBS HMO/PPO

The percentage of adolescents who had at least 2 HPV vaccines with dates of service at least 146 days apart on or between the patient’s 9th and 13th birthdays. (The deadline for the 2nd vaccination is the patient’s 13th birthday.) 

Inclusion:

Patients who turn 13 in 2021

Exclusion:

Patients in hospice

Optional exclusion:  Adolescents who had a contraindication (Anaphylactic reaction to the vaccine or its components). This exclusion can only be used if the vaccine was not administered.

Minimum/Maximum Thresholds 2021:

Minimum Threshold: 16.8%

Maximum Threshold: 48%

If you have any questions about this measure please contact Jennifer Andersen Jennifer.S.Andersen@Lahey.org or Laureen Viel Laureen.Viel@Lahey.org